Rakuten Medical IPO

rakuten-med.com

Rakuten Medical is a biotechnology company focused on developing precision, cell-targeting investigational therapies on its IlluminoxTM platform, which, in pre-clinical studies have shown to lead to rapid and selective cell killing and tumor necrosis.

Founded2013
Total Funding to Date$655.92MM
Register for Details

For more details on financing and valuation for Rakuten Medical, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Rakuten Medical Ticker Symbol

Rakuten Medical does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Rakuten Medical Stock Price

The stock price for Rakuten Medical will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Rakuten Medical Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
7/28/2021 Series D $1.71B $XXX.XX $XXX.XX
12/31/2020 Series C-2 $1.5B $XXX.XX $XXX.XX
7/31/2019 Series C-1 $1.11B $XXX.XX $XXX.XX
12/21/2018 Series C $809.7MM $XXX.XX $XXX.XX
9/12/2017 Series B-1 $213.26MM $XXX.XX $XXX.XX
10/5/2016 Series B $119.8MM $XXX.XX $XXX.XX
7/30/2015 Series A $68.25MM $XXX.XX $XXX.XX
Based on primary financings

Other companies like Rakuten Medical in the Healthcare sector

Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$4.8B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM